From: Measuring medication adherence in patients with incident hypertension: a retrospective cohort study
 |  | Range | Mean (SD) | Median (IQR) | Proportion ≥0.80 | |
---|---|---|---|---|---|---|
Overall | MPRi | 0.04–1.00 | 0.83 (0.23) | 0.95 (0.75, 0.99) | 71.8% | |
MPRp | 0.04–1.00 | 0.87 (0.19) | 0.96 (0.82, 1.00) | 76.7% | ||
PDC | 0.08–1.00 | 0.82 (0.23) | 0.93 (0.72, 0.99) | 67.9% | ||
Age | 65 to 74 years | MPRi | 0.08–1.00 | 0.82 (0.23) | 0.93 (0.72, 0.99) | 67.9% |
MPRp | 0.09–1.00 | 0.85 (0.21) | 0.95 (0.78, 1.00) | 73.6% | ||
PDC | 0.08–1.00 | 0.82 (0.23) | 0.93 (0.72, 0.99) | 67.9% | ||
75 years and over | MPRi | 0.04–1.00 | 0.84 (0.22) | 0.95 (0.77, 0.99) | 73.4% | |
MPRp | 0.04–1.00 | 0.87 (0.19) | 0.96 (0.83, 1.00) | 77.9% | ||
PDC | 0.04–1.00 | 0.84 (0.22) | 0.95 (0.77, 0.99) | 73.4% | ||
Sex | Male | MPRi | 0.04–1.00 | 0.82 (0.23) | 0.94 (0.73, 0.99) | 67.9% |
MPRp | 0.04–1.00 | 0.85 (0.21) | 0.95 (0.80, 1.00) | 73.6% | ||
PDC | 0.04–1.00 | 0.82 (0.23) | 0.94 (0.73, 0.99) | 67.9% | ||
Female | MPRi | 0.10–1.00 | 0.84 (0.22) | 0.96 (0.78, 0.99) | 73.4% | |
MPRp | 0.08–1.00 | 0.87 (0.19) | 0.96 (0.82, 1.00) | 77.9% | ||
PDC | 0.10–1.00 | 0.84 (0.22) | 0.96 (0.78, 0.99) | 73.4% | ||
Income | Lowest quintile | MPRi | 0.05–1.00 | 0.83 (0.24) | 0.95 (0.77, 0.99) | 73.1% |
 | MPRp | 0.04–1.00 | 0.87 (0.20) | 0.96 (0.83, 1.00) | 77.9% | |
 | PDC | 0.05–1.00 | 0.83 (0.24) | 0.95 (0.77, 0.99) | 73.1% | |
Highest quintile | MPRi | 0.10–1.00 | 0.85 (0.20) | 0.95 (0.74, 0.99) | 71.7% | |
Charlson comorbidities | 0 or 1 comorbidities | MPRi | 0.04–1.00 | 0.84 (0.22) | 0.95 (0.76, 0.99) | 72.6% |
MPRp | 0.08–1.00 | 0.87 (0.19) | 0.96 (0.82, 1.00) | 77.2% | ||
PDC | 0.04–1.00 | 0.84 (0.22) | 0.95 (0.76, 0.99) | 72.6% | ||
2+ comorbidities | MPRi | 0.05–1.00 | 0.79 (0.26) | 0.92 (0.61, 1.00) | 63.9% | |
MPRp | 0.04–1.00 | 0.83 (0.23) | 0.94 (0.77, 1.00) | 71.5% | ||
PDC | 0.05–1.00 | 0.79 (0.26) | 0.92 (0.61, 1.00) | 63.9% |